“Investor sentiment follows price, and the pricing narrative in this space has definitely become more optimistic in the second half of 2025 relative to the first half” by Marketing | Jan 14, 2026 | Market Notes, Media NotesUS biotech sector poised for 2026 rebound as IPO interest revives